drugset / Trial / NCT00345657

Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care

NCT00345657

Phase 4 Completed 100 enrolled In His Image Kos Pharmaceuticals · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the benefits of combination niacin ER/lovastatin in patients receiving standard care who are not at LDL goal per ATP III guidelines.

Timeline

Start
2003-07
Primary completion
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lovastatin Small molecule
Subject Niacin Small molecule